• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Dr. Reddy's Laboratories Ltd.
    13 May 2025
    1248.10
    0.27%
    Dr Reddy's stepping up focus on Indian market
    Business Line
    To be among the top five players, Dr Reddy's is adopting a multi-pronged strategy of bringing more innovative products and catering to the needs of consumer health and digital health products
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    Margin pressures, growth triggers to weigh on Dr Reddy's Laboratories
    Business Standard | 13 May 2025
    logo
    Lupin Ltd.
    13 May 2025
    1973.60
    -0.39%
    Lupin shares gain 4% on Tolvaptan Tablets launch in US; details here
    Business Standard
    Lupin, in a release, said that it holds the exclusive first-to-file status for this product and will have 180-day generic drug exclusivity
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. is trading above its 100 day SMA of 1960.5
    logo
    Sun Pharmaceutical Industries Ltd.
    13 May 2025
    1631.20
    -0.31%
    Why Sun Pharma Could Face Pricing Pressure Due To Trump's Drug Cost Reductions
    Why Sun Pharma Could Face Pricing Pressure Due To Trump's Drug Cost Reductions
    NDTV Profit
    At the heart of this proposal is the revival of the 'Most Favored Nation' pricing model, which could have implications for companies like Sun Pharmaceutical.
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical I.. has an average target of 2050.25 from 8 brokers.
    logo
    Morepen Laboratories Ltd.
    12 May 2025
    49.23
    0.86%
    Morepen Laboratories Q4 Results: Net Profit Dips 31% To Rs 20 Crore
    Morepen Laboratories Q4 Results: Net Profit Dips 31% To Rs 20 Crore
    NDTV Profit
    The company's total income rose to Rs 470 crore, up from Rs 427 crore in the corresponding quarter of the previous year, according to a regulatory filing.
    Copy LinkShare onShare on Share on Share on
    Morepen Laboratories Ltd. has lost -24.68% in the last 3 Months
    Morepen Lab Q4 net profit falls 31% to 20.31 cr, income up 10% at 470 cr
    Business Standard | 12 May 2025 1 more
    Morepen Lab Q4 net profit falls 31%
    Business Line | 12 May 2025
    logo
    Aurobindo Pharma Ltd.
    12 May 2025
    1093.30
    0.67%
    Broker's call: Aurobindo Pharma (Buy)
    Business Line
    Motilal Oswal
    Copy LinkShare onShare on Share on Share on
    Promoters pledged 0.16% of shares in last quarter. Total pledge stands at 17.08% of promoter holdings
    Aurobindo Pharma Gets 'Buy' Upgrade From Motilal Oswal On Attractive Valuations
    NDTV Profit | 12 May 2025 1 more
    Aurobindo Pharma Gets 'Buy' Upgrade On Promising Growth Prospects
    NDTV Profit | 12 May 2025
    logo
    Piramal Pharma Ltd.
    12 May 2025
    198.47
    -0.29%
    Piramal Pharma To Invest $90 Million In US Site Expansions
    Piramal Pharma To Invest $90 Million In US Site Expansions
    NDTV Profit
    Through this investment, the company is betting on the benefits offered by US-based innovation.
    Copy LinkShare onShare on Share on Share on
    Piramal Pharma Ltd. is trading below its 100 day SMA of 200.2
    logo
    Pfizer Ltd.
    12 May 2025
    5222.50
    1.39%
    Trump Vows US Drug Price Cuts Of Up To 80% In Pharma Industry Blow
    Trump Vows US Drug Price Cuts Of Up To 80% In Pharma Industry Blow
    NDTV Profit
    Shares in US drugmakers dropped before the official open on trading in New York, with Eli Lilly & Co., Pfizer Inc., Bristol-Myers Squibb Co. and Merck & Co. Inc. all down.
    Copy LinkShare onShare on Share on Share on
    Pfizer Ltd. has gained 30.00% in the last 6 Months
    logo
    Cipla Ltd.
    12 May 2025
    1517.70
    0.31%
    Cipla Q4 Results: Date, Dividend, Earnings Conference Call Details And More
    Cipla Q4 Results: Date, Dividend, Earnings Conference Call Details And More
    NDTV Profit
    Cipla is set to announce its financial results for the fourth quarter and full financial year 2024-25 on May 13.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 1114 to 1124 in Jun 2025 qtr.
    logo
    Dr. Reddy's Laboratories Ltd.
    12 May 2025
    1248.10
    0.27%
    Dr. Reddy's Share Price Gains Following Q4 Profit Beat
    Dr. Reddy's Share Price Gains Following Q4 Profit Beat
    NDTV Profit
    The company's revenue rose by 20% to Rs 8,528 crore, compared to the Bloomberg estimate of Rs 8,359.7 crore.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    Dr. Reddy's Q4 Results Review: Share Dip In Gross Margins Offset By One-Offs; 'Hold' The Stock Says Systematix
    NDTV Profit | 12 May 2025
    logo
    Dr. Reddy's Laboratories Ltd.
    09 May 2025
    1248.10
    0.27%
    Dr Reddy's Q4 results: Profit rises 22% to 1,594 crore on record revenue
    Business Standard
    Dr Reddy's posts highest-ever quarterly revenue and profit in Q4 FY25 with strong growth in generics, PSAI and NRT acquisition; FY25 PAT up 2 per cent at 5,654 crore
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 911 to 917 in Jun 2025 qtr.
    Dr Reddy's Q4 FY25 net up 21% at 1,587 crore
    Business Line | 09 May 2025 5 more
    Dr Reddy's Q4 result: Net profit rises 22% to 1,594 cr, dividend declared
    Business Standard | 09 May 2025
    Dr Reddy's Laboratories Declares Dividend Of Rs 8 Per Share
    NDTV Profit | 09 May 2025
    Dr. Reddy's Laboratories Q4 Results: Profit Rises 22%, Beats Estimate
    NDTV Profit | 09 May 2025
    Dr Reddy's Labs Q4 Results: Cons PAT jumps 22% to Rs 1,594 crore; Rs 8 per share dividend …
    Economic Times | 09 May 2025
    Dr Reddy's likely to post 15-18% growth in Q4, FY25
    Business Line | 09 May 2025
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • DSM Fresh Foods
    • Greenleaf Envirotech
    • NSB BPO Solutions
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)